On the other hand, TMEM26 is also expressed in ERα-negative breast cancer, where a high TMEM26-specific immunoreactivity is significantly associated with unfavorable survival, suggesting different functions of TMEM26 in ERα-positive and -negative breast cancers. This evidence concerns the gene ESR1 and breast cancer.